Prosight Management »

Zymeworks Del shares owned by Prosight Management

Quarter-by-quarter ownership of Zymeworks Del (ZYME) shares owned by Prosight Management from 13F filings

Historical chart of Prosight Management investment in Zymeworks Del

Tip: Access up to 7 years of quarterly data

All positions including Zymeworks Del held by Prosight Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zymeworks Del by Prosight Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $675k 106k 6.34

More positions owned by Prosight Management

Pacira Pharmaceuticals (PCRX)
Humana (HUM)
Galapagos Nv Spon Adr (GLPG)
Meiragtx Holdings (MGTX)
Kura Oncology (KURA)
BioCryst Pharmaceuticals (BCRX)
Oric Pharmaceuticals (ORIC)
Medtronic SHS (MDT)
Abcellera Biologics (ABCL)
Mirum Pharmaceuticals (MIRM)
Neurocrine Biosciences (NBIX)
Inari Medical Ord (NARI)
Inspire Med Sys (INSP)
Option Care Health Com New (OPCH)
Quidel Corp (QDEL)

View all positions for Prosight Management

Top funds holding Zymeworks Del

EcoR1 Capital
BVF
Redmile Group
Vanguard Group
Credit Suisse
Bnp Paribas Investment Partners
Samsara BioCapital
Tang Capital Management
Perceptive Advisors
Deutsche Bank Aktiengesellschaft
AQR Capital Management
Jupiter Asset Management
Jacobs Levy Equity Management
Arrowstreet Capital, Limited Partnership
Picton Mahoney Asset Management

View all funds holding Zymeworks Del